Navigation Links
'Heroes of Chemistry': Developed new drugs and technology to cut heating and cooling bills
Date:8/19/2012

PHILADELPHIA, Aug. 19, 2012 The scientists behind three inventions that touch the lives of millions of people around the world will be inducted into a coveted scientific "Hall of Fame" today as the latest Heroes of Chemistry named by the American Chemical Society (ACS), the world's largest scientific society.

The ceremony, held at the 244th ACS National Meeting & Exposition, which continues here through Thursday, will confer public recognition on scientific teams that developed:

  • The first oral drug for the most common and difficult-to-treat form of chronic hepatitis C, which infects more than 3 million people in the United States and 130-170 million worldwide.

  • Another new medicine for one form of adult leukemia that provided patients with an alternative treatment when the disease became drug-resistant.

  • The process, used around the world, for making "low-e window glass" and other glass coatings that saves millions of dollars each year in heating and cooling costs and significantly lowers energy consumption.

Established in 1996, the ACS Heroes of Chemistry program recognizes scientists whose work in various fields of chemistry and chemical engineering has led to the successful innovation and development of commercial products that benefit humankind.

Scientists from Merck, the global pharmaceutical firm known as MSD outside the United States and Canada, won the honor for developing the chronic hepatitis C drug Victrelis (boceprevir). They are Ashok Arasappan, Ph.D.; Frank Bennett, Ph.D.; Stphane Bogen, Ph.D.; F. George Njoroge, Ph.D.; and Srikanth Venkatraman, Ph.D.

Victrelis was the first oral hepatitis C virus protease inhibitor approved by the U.S. Food and Drug Administration for use in combination with pegylated interferon alfa and ribavirin, to treat the most common type of chronic hepatitis C. Chronic hepatitis C is a viral infection that affects more than 130-170 million people worldwide and can cause serious liver damage.

Scientists from Novartis, the global pharmaceutical company, won the honor for developing the leukemia drug Tasigna (nilotinib). They are Paul Manley, Ph.D.; Gabriele Fendrich, Ph.D.; Werner Breitenstein, Ph.D.; and Sandra Jacob, Ph.D. Tasigna is a prescription medication for adults with newly diagnosed form of Philadelphia chromosome-positive chronic myeloid leukemia and for patients who are resistant or intolerant to previous treatment.

Scientists from Arkema, Inc., a global producer of industrial chemicals won the honor for developing atmospheric pressure chemical vapor deposition technology. They are Dave Russo, Ph.D.; Jeff Stricker, Ph.D.; Georg Lindner; Jeremy Nihart; Ryan Smith, Ph.D.; Connie Lo; Jing Ming Mai; and Clem McKown. The technology deposits coatings of various chemicals onto the surface of glass, providing significantly increased solar heat gain control.

"Heroes of Chemistry are a visible reminder of the innovation, vitality and talent that our profession offers to society," said Bassam Z. Shakhashiri, Ph.D., ACS president. "Chemistry serves as the foundation for so many aspects of our lives. Chemistry is new products, new materials and a new hope for the future.

"We are honoring innovations that result from the support and vision of corporate management who invest in science, understand its application and advocate for it within their organizations. The corporate leaders at Arkema, Merck and Novartis have demonstrated the commitment that leads to breakthrough products and groundbreaking technologies. I salute each of these companies for creating the internal environment the culture that leads to scientific discovery and commercialization."


'/>"/>
Contact: Michael Bernstein
m_bernstein@acs.org
215-418-2056 (Philadelphia Press Center, Aug. 17-23)
202-872-6042

Michael Woods
m_woods@acs.org
215-418-2056 (Philadelphia Press Center, Aug. 17-23)
202-872-6293
American Chemical Society


Source:Eurekalert

Related medicine news :

1. Clinical trials start for stroke drug developed by Scripps Research, USC, and ZZ Biotech
2. New Facebook app to detect pedophiles and criminals developed by Ben-Gurion U. researchers
3. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
4. FDA clears test developed in partnership with VCU researcher
5. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
6. Power generation technology based on piezoelectric nanocomposite materials developed by KAIST
7. Research shows efficacy of treatment model developed at Women & Infants
8. University of Colorado Cancer Center earns major grant to develop new bladder cancer drugs
9. GWU consensus report outlines new approaches for evaluating benefits and risks of obesity drugs
10. Existing drugs offer new treatment options for high-risk childhood leukemia subtype
11. Diabetes drugs taken by over 15 million Americans raises risk of bladder cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and ... Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD ... that can be easily incorporated into liquid products, while reducing costs to end users. ...
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:10/2/2017)... ORLANDO, Fla. , Oct. 2, 2017  AllianceRx ... services company formed by Walgreens and pharmacy benefit manager ... of its new brand, which included the unveiling of ... Fla. , as well as at a few ... introduces the new brand to patients, some of whom ...
Breaking Medicine Technology: